Warning against New Nicotine Product Infiltrating Schools in New Zealand

Regulations by 2FIRSTS.ai
Apr.17.2024
Warning against New Nicotine Product Infiltrating Schools in New Zealand
New Zealand health professionals warn about the growing presence of ZYN nicotine pouches in schools, posing addiction risks.

According to a report from The New Zealand Herald on April 17th, health professionals in New Zealand are issuing warnings about a new type of nicotine product that is infiltrating schools in New Zealand. ZYN is a brand of smokeless nicotine pouches that is gradually becoming mainstream through social media influencers on platforms such as TikTok and Instagram.

 

This product, based in Sweden, aims to be a replacement for smoking or e-cigarettes to help users quit nicotine.

 

Richard Edwards, professor at the University of Otago and co-director of Aspire2025, expressed concern to the Pioneer Press about the widespread acceptance of these products among young people.

 

While these products may not be as harmful as smoking, they may still be just as addictive, leading to widespread use among young people and creating a widespread dependency on nicotine.

 

Edwards warned that unlike other nicotine pouch brands such as Snus, ZYN brand does not contain tobacco. These nicotine pouches resemble small tea bags and are placed between the lip and gum. They are typically sold in brightly colored cans of 15 to 20, and come in various flavors including berry, coffee, and citrus.

 

New Zealand banned the sale of nicotine pouches in 2020, but importing them from overseas remains legal as long as they are not sold within the country. Despite the ban, The Pioneer newspaper has learned that these products are now making their way into schools nationwide, with reports of students selling them to their peers.

 

However, Sean Teddy, the head of operations and integration at the Ministry of Education, stated that the schools have not raised any concerns about this issue with the department.

 

He emphasized,

 

According to the revised Smoke-free Environments and Regulated Products (Vaping) Amendment Act 2020, smoking or using e-cigarettes on school grounds, kura kaupapa (Māori language schools), early childhood education centers, and kōhanga reo (Māori language immersion preschools) is illegal.

 

In an earlier statement, Deputy Health Minister Casey Costello hinted that she hopes to introduce oral nicotine products, including snus and chewing tobacco, to provide smokers with more and safer alternative smoking options.

 

However, Edwards believes that the introduction of oral nicotine products may not work as expected. Edwards is concerned that these oral nicotine products may not target the intended demographic. He said, "The biggest users of e-cigarettes are young people...we want 50-year-old smokers." He expressed that allowing these products to enter the market without restrictions could lead to more young people becoming dependent on nicotine.

 

Edwards believes that these products should not be introduced unless there are very strong reasons to do so. He suggests that a distribution model similar to that of pharmacies selling only prescription drugs could be implemented, thereby more strictly regulating distribution. However, if these products are widely available in locations such as convenience stores and gas stations, we may see another product being widely used among young people.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Philip Morris International (PMI) has introduced the airport-exclusive limited-edition IQOS ILUMA i PRIME Skylens, the company’s first device created specifically for airport travel retail. Inspired by the world of flight and finished in metallic blue, Skylens debuted at Narita International Airport in Japan before expanding into selected airport duty-free and travel-retail channels across 13 countries in Europe, Asia, the Middle East and Africa. The product retains the existing IQOS ILUMA i PRIME platform, with differentiation centered on airport exclusivity, design and travel-retail execution rather than a new heating architecture.
PMI
Aug.19
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
According to Irish media outlets Highland Radio and BreakingNews.ie, the Irish government is considering whether to adjust vape tax policy in the 2027 Budget. The tax has generated about €22 million ($24 million) in revenue during its first nine months. While no increase has been confirmed, the revenue performance could influence future fiscal discussions. Any tax rise could increase product costs and potentially affect retail prices.
Aug.12
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
The UK Department of Health and Social Care published new guidance on Aug. 11 outlining the next phase of retail rules under the Tobacco and Vapes Act 2026, which will take effect on Oct. 29, 2026. The measures extend the minimum age of sale of 18 to all vaping and consumer nicotine products and restrict proxy purchasing, promotional giveaways and substantial discounts. Relevant offences in England, Wales and Scotland may carry a £200 fixed penalty notice, while persistent offenders can face temporary sales bans.
Aug.12